Background Behavioural interventions are frequently used to address sleep problems in people with intellectual disabilities (ID). The current study aimed to systematically review evidence on the efficacy of behavioural interventions for children and adults with ID and sleep problems. Method Electronic and hand searches identified seven studies for inclusion (N = 169). Standardised mean difference effect sizes (d) were calculated for group studies (N = 4). Non-overlap effect sizes (Tau-U) were calculated for single case experimental design studies (SCEDs; N = 3). Results A large effect size (weighted d = 0.923, confidence interval: 0.705 to 1.151) across group studies indicated large improvements in sleep problems following behavioural intervention. Effect size across SCEDs (weighted Tau-U: 0.528, confidence interval: 0.351 to 0.705) indicated a 53% improvement compared with baseline. Sleep initiation and sleep maintenance problems showed significant improvements post-intervention. Follow-up effects were less consistent across study designs and suggested that some sleep problems maintain gains better than others.
Introduction
Studies have suggested that up to 50% of adults with an intellectual disability (ID) and up to 80% of children with ID experience sleep difficulties (Johnson 1996; Brylewski & Wiggs 1998) , which are likely to last for several years (Richdale et al. 2000) . Sleep problems can have a significant impact on the individual's health and daytime functioning (Durand et al. 1995; Hylkema & Vlaskamp 2009) . Parents and carers are also likely to experience increased levels of stress and sleep deprivation (Wiggs & Stores 1998) . Sleep problems often go untreated, as they are seen as an unavoidable aspect of ID (Stores 1996) and not as a key mental health issue by professionals (Mindell & Owens 2003) .
The terms 'sleep problems' and 'sleep difficulties' have been used interchangeably across studies to describe different symptoms such as difficulties going to sleep, night wakings and sleeping alone (Christodulu & Durand 2004) . However, there is no uniform definition of what constitutes a sleep problem. The 'International Classification of Sleep Disorders -Third Edition' (ICSD-3 2014) identifies a range of different factors that contribute to a diagnosis. In the present study, we have focused on sleep quantity, quality, timing and sleep-disruptive behaviours, as these are commonly reported in most published studies. We use the terms 'sleep problems' and 'sleep difficulties' to refer to difficulties across three broad phases: sleep initiation, sleep maintenance and rising.
Interventions fall in two broad approaches: pharmacological and behavioural (Didden & Sigafoos 2001) . Pharmacological treatments generally aim to induce sleepiness and decrease sleep latency. As sedatives can have various side effects and interact with other medications (Doran et al. 2006) , it is argued that melatonin should be the preferred pharmacological approach (Bramble & Freehan 2005) . Melatonin is a hormone produced by the pineal gland that controls sleep and wake cycles (Turk 2003) . In a meta-analysis of nine studies (Braam et al. 2009 ), melatonin had a significant positive effect on sleep latency, night awakenings and sleep duration. A recent review has also reported a reduction in sleep onset difficulties for children with neurodevelopmental disorders, most of whom had an ID (Schwichtenberg & Malow 2015) , and practitioners support the use of melatonin with this population (Bruni et al. 2015) . However, melatonin is not licenced for prescribing for sleep problems in many countries (Braam et al. 2009 ). Moreover, its efficacy for night-time awakenings and total sleep duration has not been supported by all studies (c.f. Phillips & Appleton 2004) , and some evidence suggested that it is actually no more effective than brief behavioural interventions (Appleton et al. 2012) . In addition to these, the lack of knowledge about its long-term effectiveness suggests that melatonin cannot be considered a panacea, and alternative treatment approaches, such as behavioural, are worth investigating further.
Behavioural interventions use technologies from applied behaviour analysis (Cooper et al. 2007 ) to teach individuals how to fall asleep, which relates to both sleep initiation and maintenance. Behavioural technologies used as part of sleep interventions aim to increase the frequency of behaviours promoting sleep while decreasing the frequency of behaviours interfering with sleep (such as night-time awakenings). Techniques are also used to assist individuals with rising once they have woken up. Behavioural interventions for individuals with ID are typically delivered by parents or carers. They include positive reinforcement for desirable behaviour, ignoring undesirable behaviour (extinction) and environmental modifications (e.g. stimulus control). The latter is a broad category of technologies that can include things like removing the television from the bedroom, only going to bed when tired, giving clear instructions, clear bedtime routines, engaging in activity during the day and a change in daily routine. Most behavioural interventions were originally developed for typically developing children (for a review, see France & Hudson 1993) . As they involve simple verbal communication, environmental modifications and adjustments in the carer/parent behaviour, they are also suitable for individuals across a wide range of cognitive abilities.
For individuals without ID, reviews have suggested that behavioural interventions are effective for improving a variety of sleep problems (Mindell 1999; Kuhn & Elliott 2003; Irwin et al. 2006; Mindell et al. 2006) . Some of these have included evidence from ID, although this is very limited. Meltzer and Mindell's recent meta-analysis (2014) included two studies of individuals with 'special needs' in addition to 26 studies of typically developing people. Findings from these two studies indicated no significant gains for special needs populations. It should, however, be noted that only one of the two studies included children with ID (in the second study, children only had autism, not ID), suggesting that Meltzer & Mindell's (2014) findings cannot be generalised to the population of individuals with ID. A recent review by Spruyt & Curfs (2015) included, among others, three studies of people with ID. Although a variety of benefits were reported across studies, no breakdown was provided in relation to those with ID. Furthermore, participants in two of these studies also had autism, whereas the remaining case study focused on bedwetting rather than sleep difficulties per se. The Spruyt & Curfs (2015) review focused on several nonpharmacological approaches, not just behavioural interventions. To the best of our knowledge, no systematic review has sufficiently examined whether behavioural interventions work well for people with ID, despite the fact that these techniques are regularly used in clinical practice with this population. Recently, van de Wouw et al. (2012) conducted a systematic review on various aspects of sleep problems among adults with ID, including reviewing the efficacy of behavioural interventions. They identified 13 studies, 11 of which were case studies. The authors suggested that the available evidence supported the potential of behavioural interventions in treating sleep problems in this population; however, no data were actually synthesised (van de Wouw et al. 2012) . Furthermore, no study has reviewed or synthesised available evidence for children with ID.
Several evaluations of behavioural interventions employ single case experimental designs (SCEDs), whereby an individual is exposed to different conditions and the outcome is measured repeatedly across and within conditions (Kratochwill et al. 2010) . This experimental design is common in behavioural research as interventions and evaluations are customised to match participant's unique profile and needs. The present review and meta-analysis aimed to include evidence from both SCEDs and group designs, in a novel approach that aimed to integrate different sources of evidence in a single synthesis.
Methods

Eligibility criteria
Studies needed to meet the following criteria to be included in the analysis:
• Studies must meet the current study ' 
Study selection
After screening titles and abstracts, 210 studies were removed for not meeting the inclusion criteria. The remaining 57 articles were then read in full to assess eligibility, and seven studies were identified as meeting the inclusion criteria (the process is summarised in Fig. 1 using a Preferred Reporting Items for Systematic Reviews and Meta-analyses flowchart). Two studies adopted a single group design (Bramble 1997; Hylkema & Vlaskamp 2009) , two were RCTs (Wiggs & Stores 1998; Montgomery et al. 2004 ) and three were SCEDs using a multiple baseline (Thackeray & Richdale 2002; Gunning & Espie 2003; Weiskop et al. 2005) .
The single group studies included 56 participants, and the RCTs included 57 intervention participants plus 39 control participants. All group studies included one treatment condition, except for Montgomery et al. (2004) that included one faceto-face intervention group and a booklet intervention group. In the SCED studies, six participants from the Weiskop et al. (2005) study were excluded (five participants with autism and one with Asperger's syndrome) because of lack of information regarding the presence of ID. This left a total of 17 suitable SCED participants. Overall, the meta-analysis included N = 130 intervention recipients, plus N = 39 control participants (Table 1) .
Methodological quality of the included studies was coded using the evaluative method (Reichow et al. 2008) , a rating system that is applicable to both group and SCEDs. This method provides a single rating for the methodological rigour of each study (strong, adequate and weak) and criteria for synthesising ratings from SCEDS and group studies to determine the level of evidence-based support for an intervention ('established' or 'promising' evidencebased practice). Initially developed in the field of Adequate.
RCT, randomised control trial; SCED, single case experimental design; CSI, Composite Sleep Index; m, male; f, female. *The fourth participant withdrew from the original study. † Three of the 12 participants originally recruited to the original study withdrew before completion. ‡ Six participants were excluded from the meta-analysis as there was no evidence of ID. A further participant dropped out of the original study.
autism (Reichow et al. 2008; Cicchetti 2011) , it can be extended to other fields, and it has demonstrated it can reliably distinguish between studies of different quality (Wendt & Miller 2012) . Using this method, one study was assessed as 'strong' (Wiggs & Stores 1998) , and the remaining were 'adequate' ( Table 1) .
Data extraction
Information for each study was extracted on study design (RCT, single group or SCED), N, participant gender and age, type of intervention and outcome data. Two variables were coded for subsequent subgroup analysis: data source (parent/carer rated diary data vs. actigraphy data) and sleep problem phase (sleep initiation vs. sleep maintenance; only one study included rising data). Outcome data obtained from group studies were means and standard deviations. Data from SCEDs were extracted from graphs using a pencil and ruler.
Statistical analysis
As three different study designs were included, a different method of effect size derivation was used in each instance. For single group studies and RCTs, standardised mean differences were estimated. In single group studies, the mean difference between the post-intervention and pre-intervention outcomes was divided by the standard deviation of change scores while accounting for the pre-post correlation between scores on the outcome measure (Dunlap et al. 1996) . In RCTs, the mean pre-post difference for the treatment group was subtracted from that of the control group and divided by the pooled standard deviation of change scores (Higgins & Green 2011) .
As standardised mean differences, their interpretation follows Cohen's (1988) conventions (d = 0.2 small, d = 0.5 moderate and d = 0.8 large). Confidence intervals that include the value of zero indicated a non-significant effect size. For SCEDs, Tau-U was used to evaluate the percentage improvement over baseline (Parker et al. 2011a (Parker et al. , 2011b . The Tau-U is a non-overlap effect size appropriate for SCEDs that has demonstrated several advantages over other nonoverlap effect sizes: it accounts for any potential baseline trend that, if unaccounted, can compromise the validity of the findings; it does not suffer from ceiling or floor effects; and it is very powerful (Parker et al. 2011a (Parker et al. , 2011b . Tau-U scores typically range from 0 to 1, with 0 indicating 0% improvement while Tau-U = 1 would suggest 100% improvement compared with before the intervention (baseline). Finally, summary effect sizes were weighted by the inverse of variance. Effect sizes presented in tables were estimated to indicate improvement; therefore, negative signs indicate deterioration. Details of the effect size calculations can be found in Appendix 1.
Results
Description of studies
Single group studies
In Bramble (1997) , 15 children with severe ID (aged 3.5 to 12 years) and severe night-settling and night-waking problems received intervention including sleep-wake scheduling, maintaining a bedtime routine, extinction and positive reinforcement. 
Meta-analysis
Group studies 
297).
The overall effect size from all group studies suggested a significant large effect (d = 0.928, 95% CI: 0.705 to 1.151) pre-post (Table 3) . Interestingly, the overall effect size from RCTs indicates a very strong effect (d = 1.608, 95% CI: 1.215 to 2), and this is significantly higher than the moderate effect obtained from single group studies (d = 0.588, 95% CI: 0.312 to 0.864). There was a very large pre-follow-up effect size (d = 1.573, 95% CI: 1.234 to 1.912; Table 3 ). This was significantly larger from that at pre-post, indicating that the beneficial effects of behavioural interventions on sleep problems increase over time. When comparing the overall effect sizes between the two different types of group designs, at follow-up, both RCTs and single group studies showed very large significant effects (d = 1.264, 95% CI: 0.68 to 1.852; d = 1.725, 95% CI: 1.313 to 2.137, respectively), although the RCT effect size was based on data from one study only.
Single case experimental designs
The first part in Table 4 presents the effect sizes (Tau-U) for each type of sleep problem across all SCED participants. Results indicated that, with the exception of bedtime disturbances, all sleep problems improved significantly between baseline and intervention. The largest gains were seen for falling asleep independently and falling asleep in own bed, with an 85% and 66% improvement, respectively. Co-sleeping improved by 46%, sleep onset latency by 58%, night waking by 50% and total sleep duration by 63%.
Summarising the effects across behaviours and participants, an overall Tau-U of 0.528 (95% CI: 0.351 to 0.704; last row, Table 4 ) suggested an overall significant improvement of about 53% over baseline. The baseline-follow-up overall Tau-U was nonsignificant and had very large confidence intervals (Tau-U = 0.653, 95% CI:À1.451 to 2.757), suggesting that longer-term gains became too variable. Specific sleep behaviours where improvements are still significant at follow-up were co-sleeping (Tau-U = 0.487, 95% CI: 0.047 to 0.927), falling asleep independently (Tau-U = 1, 95% CI: 0.02 to 1.98) and sleep onset latency (Tau-U = 0.822, 95% CI: 0.614 to 1.03). The non-significant Tau-U for falling asleep in own bed, night waking and total sleep duration indicate that any intervention effects for these problems may fade with time. Increased variability that renders these effects non-significant suggests that these types of sleep problems would benefit from further input to retain gains. Overall, SCED effect sizes suggested large and significant gains following behavioural intervention, and good maintenance for some, but not all types of sleep problems.
Subgroup analyses
We aimed to explore the effect of data source (parent/ carer diary vs. actigraphy data) and sleep phase (sleep 9 As only one study contained follow-up control group data (Wiggs & Stores 1998) , the mean effect size of that study is reported rather than a weighted value.
initiation vs. sleep maintenance) on overall pre-post effectiveness. All SCED data were collected using diaries, which meant that the SCED diary Tau-U was the same as the overall SCED (Tau-U = 0.528, 95% CI: 0.351 to 0.704). Diary data in group studies (N = 3) indicated a very large significant diary effect size (d = 2.012, 95% CI: 1.604 to 2.22), which was also significantly higher than the moderate significant effect size for actigraphy (study N = 2; d = 0.494, 95% CI: 0.294 to 0.739). Results suggested that parent/carer rated diary data were associated with higher effect sizes. The overall SCED Tau-U for sleep initiation problems (N = 5) was 0.498 (95% CI: 0.196 to 0.8) and the Tau-U for sleep maintenance problems (N = 2) was 0.562 (95% CI: 0.264 to 0.861), suggesting significant gains for both phases of 50% and 56%, respectively. Sleep initiation in group studies (N = 2) was associated with a large significant effect size (d = 0.747, 95% CI: 0.468 to 1.02). Sleep maintenance in group studies (N = 2) was associated with a moderate significant effect size (d = 0.307, 95% CI: 0.044 to 0.560) that was not significantly different from the sleep initiation effect size, as indicated by the overlap in their confidence intervals. Behavioural interventions were similarly moderately effective for sleep initiation and sleep maintenance problems across group studies and SCEDs.
Discussion
The present study aimed to synthesise available evidence on the efficacy of behavioural interventions for sleep problems among children and adults with ID. Effect sizes indicated large significant improvements from intervention. The pre-post effect size from all group studies was close to 1 (d = 0.928, 95% CI: 0.705 to 1.151), while the effect size from SCEDs indicated a 53% improvement across all types of sleep problems (Tau-U = 0.528, 95% CI: 0.351 to 0.704). Effect sizes from both study designs were consistent in suggesting significant and substantial gains following behavioural intervention. Findings were in line with available evidence for adults and children without ID (Irwin et al. 2006; Sakakini 2011) , but contrary to Mindell et al. (2006) who suggest significant gains for individuals with ID. However, in Mindell et al. (2006) , only one study included individuals with ID.
When exploring potential moderators of effectiveness, we examined the effect of data source and sleep phase. With regard to data source, diary data were associated with a significantly higher effect size compared with actigraphy data, even though both effect sizes were significant. Results need to be interpreted with caution because of the small number of comparisons (comparison possible only in group studies). Similarly, no difference was found between 10 *Most participants were measured on more than one outcome. For the overall weighted Tau-U, every participant contributed a single Tau-U (the weighted average across all outcomes) to avoid non-independence of effect sizes when summarising across all participants. †
The increase in bedtime disturbance was attributed to an extinction burst following the withdrawal of parental attention and the impact of external factors unrelated to the study (Thackeray & Richdale 2002) .
sleep initiation and sleep maintenance, with effect sizes suggesting significant positive gains made in both phases. These findings were consistent across SCEDs and group studies and suggest that sleep problems associated with either sleep phase are likely to benefit from behavioural intervention. Using the evaluative method (Reichow et al. 2008 ), six of the seven studies were evaluated as being of adequate methodological quality, while the seventh one was strong. Following the Reichow et al. (2008) criteria on the levels of evidence base, included studies suggested that behavioural interventions for sleep problems in individuals with an ID are a promising evidence-based practice. Studies of stronger methodological quality would be required to establish this approach as an evidence-based practice.
In terms of longer-term maintenance of effects, results were less consistent across designs. The very large significant effect from group studies (d = 1.573, 95% CI: 1.234 to 1.912) suggested that gains were not only maintained but actually strengthened over time. Contrary to this, the overall follow-up effect in SCEDs was non-significant (Tau-U = 0.653, 95% CI: À1.451 to 2.757). The very wide confidence intervals in the Tau-U suggest heterogeneity in follow-up effects. One possible reason for the discrepancy is measurement accuracy. Follow-up effect sizes in group studies were mostly based on CSI scores, which are global ratings of several sleep problem behaviours. In SCEDs, specific sleep problems are measured individually. This decreases measurement accuracy, but on the other hand, it allows us more insight in the specificity of follow-up gains. Indeed, of the seven types of sleep problems measured in SCEDs, three were associated with a significant positive effect size at follow-up: co-sleeping, falling asleep independently and sleep onset latency improved by about 50% to 100% at follow-up (Table 4) . Effects were not maintained for falling asleep in own bed and night wakings. The discrepancy in the follow-up effect sizes between the two designs is very informative and suggests that longer-term gains are possible but that not all sleep problems will maintain gains; therefore, clinicians need to monitor maintenance using followup measurements of specific behaviours as opposed to global ratings. This pattern of findings mirrors followup findings in non-ID studies (Pallesen et al. 1998; Sakakini 2011) , but follow-up data are scarce (Irwin et al. 2006) ; therefore, the present findings will hopefully serve to encourage the collection of followup data in primary studies.
The present study was the first attempt to synthesise the effects of behavioural interventions for sleep problems individuals with ID. The findings are encouraging about the potential of behavioural interventions to address sleep problems in this population, and a synthesis should be repeated when more studies become available. The present metaanalysis included only seven studies, and therefore, findings should be considered as preliminary only. Future reviews should consider using broader search terms for identifying people with ID (e.g. 'mental retardation'), as the use of the terms learning/intellectual disability in the present study might have significantly limited the studies identified. A further limitation of the present synthesis is the fact that level of ID was not considered as a potential moderator of effectiveness. This was because of information not being available in all included studies. A future synthesis that includes more studies might allow for this important variable to be examined and also for potentially more specific moderator paths that explore whether certain sleep outcomes are more likely to benefit at different levels of intellectual functioning. The impact of other variables such as age, gender, culture and type of behavioural intervention should also be investigated.
A particular strength of the present study was the inclusion of both group designs and SCEDs to maximise use of available information. Our approach involved applying an effect size that was most appropriate to each type of study design included and then synthesising these either statistically (RCTs with single group studies, because both types of effect sizes were standardised mean differences) or conceptually (group studies with SCEDs). Overall effect sizes from group designs are useful in indicating the magnitude and significance of overall change, whereas overall Tau-U effect sizes convey important information regarding the clinical significance of change. The advantage of this approach is that it makes use of all available evidence, without excluding SCED data, which is often carried out, while appropriately measuring SCED effects without relying on inappropriately applied effect sizes for parametric data. In doing so, we were able to examine the evidence from each study design in a parallel way, not an additive one. Where present, differences between study designs allowed further insight into the data by highlighting different aspects of information.
In summary, the present study was a novel attempt at synthesising evidence from SCEDs and group designs to examine, for the first time, effectiveness of behavioural interventions for sleep problems in ID. The studies included in the present synthesis suggested that behavioural interventions are a promising evidence-based practice that improved sleep problems in adults and children with ID by approximately 53% (SCEDs) or a large effect size (d = 0.928) post-intervention. Problems with sleep initiation or sleep maintenance benefit similarly from behavioural interventions, while more objectively measured actigraphy data still indicated significant improvements (compared with diary data).
Improvements can be maintained but not for all types of sleep problems, suggesting more targeted input might be required. Findings support the use of behavioural interventions for sleep problems with individuals with ID, but further comparative metaanalyses are required to examine whether they are more or equally effective to pharmacological treatment. As further research is recommended regarding the maintenance of the post-intervention effects, clinicians should be mindful of their ongoing role in supporting parents and carers in the months following treatment. There is a real need for more evaluation studies in future, as sleep problems are hugely significant not only for the people who experience them but also for those who support them.
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Formula (2) SD tr.pre refers to the standard deviation prior to the intervention, and SD tr.post is the post-intervention standard deviation. Where r, a pre-post correlation coefficient was used, and when this was not available, the measure's test-retest reliability coefficient was used instead (Table 2 ). The process was repeated for follow-up data only for the Bramble study (1997), as the other one did not include follow-up data. Confidence intervals (CIs) were then calculated for each effect size: 95% CI ¼ ES ±1:96* SE Formula (3) SE refers to the standard error of the effect size (d) and was calculated using the following formula:
Effect size formulae for RCTs.
The following formula was used:
Formula (5) As the SD pooled score was not reported in any of the studies, the standard deviation of change scores within each group was calculated (Higgins & Green 2011) . The two resulting SD change scores were used to obtain an estimate of the pooled standard deviation as follows:
Formula (6) where SD tr.change is the standard deviation of change scores within the intervention group and SD cont.change is the standard deviation of change scores within the control group. The values n 1 and n 2 are the number of participants in the treatment group and control group, respectively. Confidence intervals were then obtained for each effect size using Formula (3), in which the required SE was calculated using
Formula (7)
Effect size formulae for SCEDs. Tau-U effects were calculated using this formula:
Tau À U ¼ difference between paired scores n=2
Formula (8) where n is the total number of observations for that participant, meaning that n/2 is the total number of comparisons between data-points. Tau-U scores were obtained per person for each outcome measure. Raw data were extracted from papers, and effect sizes calculated using a web application developed by Tau-U's authors (Vannest et al. 2011 ; http://www. singlecaseresearch.org/calculators/tau-u). As Tau-U scores follow the S distribution, the web application also provides P values, standard deviations and 95% confidence intervals reported in this study.
Summary effect size formulae. Summary effect sizes weighted by inverse of variance were obtained for the group studies using the following formula:
Formula (9) In the case of the group studies, 'weight i ' and 'ES i ' refer to the weight and effect size of each individual study. This is summarised as follows:
Formula (10) Overall confidence intervals were also calculated using Formula 3, where the SE of the summary effect size was
This process was carried out for the single group studies and the RCTs separately, to obtain 'pre-post' and 'prefollow up' effect sizes. Separate summary weighted effect sizes were estimated for single group and RCTs, and one overall weighted effect size across all group studies, as an overall estimate of efficacy across all group designs (Table 3) . Similarly, Tau-U effect sizes were weighted by the inverse of variance. The difference with the group design approach is that weighting takes place at two levels: within-participant and across-participants. To obtain a summary weighted Tau-U for each type of sleep problem (upper part in Table 4 ), we summarised individual Tau-U across participants who had data for this type of sleep problem. To obtain a summary weighted Tau-U across all SCED participants (last row, Table 4 ), we first estimated a weighted average Tau-U per person (across any available outcomes for this person) and then obtained a summary weighted TAu-U across all SCED participants. We used the web application but also hand calculations to obtain summary weighted Tau-U and their 95% confidence intervals. Weights were calculated using formula 10.
